{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:12:29Z","timestamp":1789737149343,"version":"4.0.1"},"reference-count":74,"publisher":"National Academy of Sciences","issue":"8","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1007980"],"award-info":[{"award-number":["1007980"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1007980"],"award-info":[{"award-number":["1007980"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Protection Society of Tasmania","award":["K26577"],"award-info":[{"award-number":["K26577"]}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2022,2,22]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>Antivirals are ineffective in treating viral pneumonia if administered after 48 h post onset of disease symptoms. Lung pathology during respiratory viral infections is triggered by the host inflammatory response and tissue damage caused by replicating virus. Therefore, targeting both virus and inflammation would be more effective in treating pneumonia. Simultaneous treatment with an anti-inflammatory drug targeting TNF or STAT3 combined with an antiviral drug significantly improved clinical disease, reduced lung viral load and pathology and protected mice from severe pneumonia caused by respiratory ectromelia virus infection. The combined treatment suppressed multiple proinflammatory cytokines and cytokine-signaling pathways, including NF-\u03baB and STAT3. Late after onset of symptoms, antiviral treatment alone cannot ameliorate viral pneumonia, as it cannot reduce inflammation effectively.<\/jats:p>","DOI":"10.1073\/pnas.2112725119","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T16:15:45Z","timestamp":1645114545000},"update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":21,"title":["Targeting ectromelia virus and TNF\/NF-\u03baB or STAT3 signaling for effective treatment of viral pneumonia"],"prefix":"10.1073","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4478-7581","authenticated-orcid":false,"given":"Pratikshya","family":"Pandey","sequence":"first","affiliation":[{"name":"Viral Immunology and Immunopathology Group, Tasmanian School of Medicine, University of Tasmania, Hobart, TAS 7000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-7749","authenticated-orcid":false,"given":"Zahrah","family":"Al Rumaih","sequence":"additional","affiliation":[{"name":"Department of Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8730-1062","authenticated-orcid":false,"given":"Ma. Junaliah Tuazon","family":"Kels","sequence":"additional","affiliation":[{"name":"Department of Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6607-3734","authenticated-orcid":false,"given":"Esther","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Kc","sequence":"additional","affiliation":[{"name":"Viral Immunology and Immunopathology Group, Tasmanian School of Medicine, University of Tasmania, Hobart, TAS 7000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3388-2102","authenticated-orcid":false,"given":"Geeta","family":"Chaudhri","sequence":"additional","affiliation":[{"name":"Department of Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6306-4405","authenticated-orcid":false,"given":"Gunasegaran","family":"Karupiah","sequence":"additional","affiliation":[{"name":"Viral Immunology and Immunopathology Group, Tasmanian School of Medicine, University of Tasmania, Hobart, TAS 7000, Australia"},{"name":"Department of Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.29.6.659"},{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-016-0996-0"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15782"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00470-2"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.icb.7100033"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2004615117"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-014-9942-x"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2013.0095"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1995.0056"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510462103"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30309-X"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2008.00751.x"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2004688117"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/385729a0"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1821068116"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2009.11.005"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13075-019-1910-2","article-title":"Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: An open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study","volume":"21","author":"Park M.-C.","year":"2019","unstructured":"M.-C. Park , Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: An open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study. Arthritis Res. Ther. 21, 122 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2004.40.4.820078"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23493"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24778"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501573"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011303432201"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.16.10068"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2013.04.003"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2010.10.017"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11830"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/45.1.7"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000034"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2008.07.003"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.9.13.1586"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61459-6"},{"key":"e_1_3_4_33_2","first-page":"CD008965","article-title":"Neuraminidase inhibitors for preventing and treating influenza in adults and children","volume":"4","author":"Jefferson T.","year":"2014","unstructured":"T. Jefferson , Neuraminidase inhibitors for preventing and treating influenza in adults and children. Cochrane Database Syst. Rev. 4, CD008965 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2019.12.005"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059060-00009"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.10.3275-3280.2003"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(01)00159-0"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1086\/315190"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2588-y"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1477"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144832"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.5.3408"},{"key":"e_1_3_4_43_2","first-page":"1238","article-title":"Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis","volume":"28","author":"Moreland L. W.","year":"2001","unstructured":"L. W. Moreland , Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis. J. Rheumatol. 28, 1238\u20131244 (2001).","journal-title":"J. Rheumatol."},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200387"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2020.11.003"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.107.4.1062"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11963"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.5.2653"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.2000.279.4.L658"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.38055"},{"key":"e_1_3_4_51_2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","article-title":"Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis","volume":"163","author":"Charles P.","year":"1999","unstructured":"P. Charles , Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J. Immunol. 163, 1521\u20131528 (1999).","journal-title":"J. Immunol."},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfv161"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12101176"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc13171"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(11)80543-7"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8140422"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-12-0528"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031994"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.2174\/1566524014666140603103138"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2018-0196OC"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24755"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1177\/2040206617691885"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1107024108"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00028510"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04559.x"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2020.1819791"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00208-15"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X10366368"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830271020"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04098-8"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpmc.65"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2014.06.010"},{"key":"e_1_3_4_74_2","unstructured":"H. Davarinejad Quantifications of western blots with ImageJ. www.yorku.ca\/yisheng\/Internal\/Protocols\/ImageJ.pdf. Accessed 28 June 2021."}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.2112725119","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.2112725119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T03:24:34Z","timestamp":1674789874000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.2112725119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,2,22]]}},"alternative-id":["10.1073\/pnas.2112725119"],"URL":"https:\/\/doi.org\/10.1073\/pnas.2112725119","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"2021-07-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2112725119"}}